
This prospective observational study, involving 8005 Systolic Blood Pressure Intervention Trial (SPRINT) participants, explored the association between longitudinal changes in N-terminal pro-B-type natriuretic peptide (NT-proBNP) during hypertension treatment and kidney function decline. A ≥25% decrease in NT-proBNP correlated with a slower estimated glomerular filtration rate (eGFR) decline, while a ≥25% increase was linked to faster eGFR decline and an increased risk of ≥30% decline in eGFR, particularly in those with baseline chronic kidney disease.
Like
Save
Share